Search - tctmd.com

Displaying 381 - 400 of 626

Sort: Relevancy | Date

Presentation TCT 2017

Preprocedural Imaging With TEE and CTA to Plan LAA Occlusion (With Discussion)

Presenter: Maurice Buchbinder, Hüseyin Ince, Ramon Quesada

October 30, 2017

Presentation TCT 2017

LAA Closure III: Postprocedure and Beyond

Presenter: Russell A. Brandwein

October 30, 2017

Presentation TCT 2017

LAA Closure II: From Consultation to Procedure

Presenter: Russell A. Brandwein, Jessica Forman

October 30, 2017

Presentation TCT 2017

LAA Closure I: From Referral to Consultation

Presenter: Russell A. Brandwein, Lindsay Thomas

October 30, 2017

Presentation TCT 2017

The Value of 3D Printed Models for Device Sizing in Percutaneous LAA Occlusion

Presenter: Nicolo Piazza, Josep Rodés-Cabau, Vlad Ciobotaru

October 30, 2017

Presentation TCT 2017

Technical Approach to Bicuspid Aortic Valves

Presenter: Martin B. Leon, Yongjian Wu, Zhen-Gang Zhao

October 29, 2017

Presentation TCT 2017

Step-By-Step LAA Occlusion Implantation Technique (Case-based)

Presenter: Alexandre Abizaid, Oscar A. Mendiz, Ricardo Quizhpe

October 29, 2017

Presentation TCT 2017

Case Presentation: TAVR in Bicuspid Aortic Stenosis With Severe Calcification

Presenter: Martin B. Leon, Yongjian Wu, Jun Jiang

October 29, 2017

Presentation TCT 2017

LAA Closure: Underused Therapy in Patients With High Bleeding Risk

Presenter: David Hildick-Smith, Lars Sondergaard, Robert A. Byrne

October 29, 2017

Presentation TCT 2017

Current Practice and Perspectives on LAAC in China

Presenter: Martin B. Leon, Yongjian Wu, Ling Tao

October 29, 2017

Presentation TCT 2017

Current Practice and Perspectives on TAVR in China

Presenter: Martin B. Leon, Yongjian Wu, Yuejin Yang

October 29, 2017

Presentation TCT 2016

Management of Residual Leaks After LAA Closure

Presenter: David R. Holmes Jr., Jacqueline Saw

November 01, 2016

Presentation TCT 2016

Assessment and Implications of Residual Leaks After Percutaneous and Surgical LAA Closure

Presenter: David R. Holmes Jr., Jacqueline Saw

November 01, 2016

Presentation TCT 2016

Reimbursement Challenges For LAAC: Balancing The Clinical Need Vs. Robust Data Vs. Societal Economic Considerations

Presenter: Aaron V. Kaplan, Rachel Neubrander, Tamara Syrek Jensen

November 01, 2016

Presentation TCT 2016

Follow-up Evaluation After LAA Closure

Presenter: David R. Holmes Jr., Jacqueline Saw, Bushra S Rana

November 01, 2016

Presentation TCT 2016

Pivotal Trial Design Considerations: Noninferiority vs Superiority, Device, Control Arm Anticoagulation Durations, NOAC Considerations and More Industry and Clinician Perspectives

Presenter: Aaron V. Kaplan, Rachel Neubrander, Brian K. Whisenant

November 01, 2016

Presentation TCT 2016

Trial Designs For LAA Closure: Potential Regulatory Pathways and Unanswered Questions What FDA Would Like to See

Presenter: Aaron V. Kaplan, Rachel Neubrander, Katherine Wallon

November 01, 2016

Presentation TCT 2016

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Presenter: Martin W. Bergmann, Samir R. Kapadia, Harvey D. White

November 01, 2016

Presentation TCT 2016

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

Presenter: Martin W. Bergmann, Samir R. Kapadia, Jason H. Rogers

November 01, 2016

Presentation TCT 2016

Special Tips and Tricks for LAA Closure Using the Lariat

Presenter: Krzysztof Bartus, Randall J. Lee

November 01, 2016

Advertisement

Preprocedural Imaging With TEE and CTA to Plan LAA Occlusion (With Discussion)

LAA Closure III: Postprocedure and Beyond

LAA Closure II: From Consultation to Procedure

LAA Closure I: From Referral to Consultation

The Value of 3D Printed Models for Device Sizing in Percutaneous LAA Occlusion

Technical Approach to Bicuspid Aortic Valves

Step-By-Step LAA Occlusion Implantation Technique (Case-based)

Case Presentation: TAVR in Bicuspid Aortic Stenosis With Severe Calcification

LAA Closure: Underused Therapy in Patients With High Bleeding Risk

Current Practice and Perspectives on LAAC in China

Current Practice and Perspectives on TAVR in China

Management of Residual Leaks After LAA Closure

Assessment and Implications of Residual Leaks After Percutaneous and Surgical LAA Closure

Reimbursement Challenges For LAAC: Balancing The Clinical Need Vs. Robust Data Vs. Societal Economic Considerations

Follow-up Evaluation After LAA Closure

Pivotal Trial Design Considerations: Noninferiority vs Superiority, Device, Control Arm Anticoagulation Durations, NOAC Considerations and More Industry and Clinician Perspectives

Trial Designs For LAA Closure: Potential Regulatory Pathways and Unanswered Questions What FDA Would Like to See

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

Special Tips and Tricks for LAA Closure Using the Lariat

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content